STORY
1
day
7
outlets
9
reports
running since
19.08
LATEST
Moderna (MRNA)’s Melanoma Vaccine Win: Big Opportunity, Bigger Expectations
finance.yahoo.com · 19.08.2026 23:58
HOW IT DEVELOPED
Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread
aljazeera.com
· 19.08 22:39
mRNA Vaccine Stocks Rise on Moderna-Merck Success
wsj.com
· 19.08 20:29
This Analyst Just Upgraded Moderna as MRNA Stock Skyrockets on Cancer Vaccine Results
finance.yahoo.com
· 19.08 19:10
Moderna and Merck Just Made History With the First mRNA Cancer Vaccine to Succeed in a Phase 3 Trial. Here's What That Means for Investors.
finance.yahoo.com
· 19.08 18:54
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
arstechnica.com
· 19.08 18:53
Promising Results for mRNA Cancer Vaccine from Moderna and Merck
time.com
· 19.08 15:49
Moderna share price doubles on melanoma vaccine trial success
ft.com
· 19.08 14:08
Moderna, Merck, La-Z-Boy, SK Hynix, and More Stocks That Explain Today’s Market
barrons.com
· 19.08 13:35
More in this section
Kenya confirms its first Ebola death as outbreak spreads
bbc.co.uk · 06.10
Ten NHS trusts referred over monitoring consent
bbc.co.uk · 06.10
'Life-saving' charity for mums faces closing support
bbc.co.uk · 06.10
Pennsylvania faces largest measles outbreak in decades as case count rises to 1,000
theguardian.com · 05.10
Trump says US ready to aid Russia with plague outbreak in Siberia
aljazeera.com · 05.10
GP 10-minute appointment slots 'making it harder to do cancer checks'
bbc.co.uk · 05.10
Other stories
Rusiya MN: Ukrayna son sutkada 1750 dron ilə hücum edib
azerbaijan · apa.az
ADY-nin sərnişin daşımaları artıb
azerbaijan · modern.az
Narqis Vik: "Orta Dəhliz investisiya-sənaye əməkdaşlığı platforması olmalıdır"
azerbaijan · report.az
Stiv Loris Gi-Dibi: "Azərbaycan ortamüddətli perspektivdə dinamik iqtisadi artım üçün baza yaradır"
azerbaijan · report.az
Güc, pul, ambisiya və xəyanət – Sem Altmanın hekayəsi Hollivudda
culture · kulis.az
The S&P 500 is facing rate chaos and narrow breadth. Why one Goldman Sachs insider is still bullish on stocks.
finance · marketwatch.com